OncoAlvo.: Technological Innovation Optimised for the Personalisation of Oncology Therapy (Q2866833): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en, pt: Fixing missing labels.) |
(Added qualifier: readability score (P590521): 0.000011549073841409742) |
||||||||||||||
(4 intermediate revisions by 2 users not shown) | |||||||||||||||
Property / start time | |||||||||||||||
| |||||||||||||||
Property / start time: 1 March 2016 / rank | |||||||||||||||
Property / end time | |||||||||||||||
| |||||||||||||||
Property / end time: 1 March 2018 / rank | |||||||||||||||
Property / budget | |||||||||||||||
| |||||||||||||||
Property / budget: 467,816.0 Euro / rank | |||||||||||||||
Property / EU contribution | |||||||||||||||
| |||||||||||||||
Property / EU contribution: 349,140.0 Euro / rank | |||||||||||||||
Property / co-financing rate | |||||||||||||||
| |||||||||||||||
Property / co-financing rate: 74.63 percent / rank | |||||||||||||||
Property / summary: None (English) / qualifier | |||||||||||||||
readability score: 0.000011549073841409742
| |||||||||||||||
Property / contained in Local Administrative Unit | |||||||||||||||
Property / contained in Local Administrative Unit: União das freguesias de Cantanhede e Pocariça / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / priority axis | |||||||||||||||
Property / priority axis: Research, Development and Innovation (DIIAS) / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / thematic objective | |||||||||||||||
Property / thematic objective: Research and innovation / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / start time | |||||||||||||||
3 January 2016
| |||||||||||||||
Property / start time: 3 January 2016 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / end time | |||||||||||||||
3 January 2018
| |||||||||||||||
Property / end time: 3 January 2018 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / budget | |||||||||||||||
346,724.18 Euro
| |||||||||||||||
Property / budget: 346,724.18 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
Property / EU contribution | |||||||||||||||
258,908.66 Euro
| |||||||||||||||
Property / EU contribution: 258,908.66 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
Property / co-financing rate | |||||||||||||||
74.67 percent
| |||||||||||||||
Property / co-financing rate: 74.67 percent / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / date of last update | |||||||||||||||
23 May 2023
| |||||||||||||||
Property / date of last update: 23 May 2023 / rank | |||||||||||||||
Normal rank |
Latest revision as of 13:27, 22 March 2024
Project Q2866833 in Portugal
Language | Label | Description | Also known as |
---|---|---|---|
English | OncoAlvo.: Technological Innovation Optimised for the Personalisation of Oncology Therapy |
Project Q2866833 in Portugal |
Statements
258,908.66 Euro
0 references
346,724.18 Euro
0 references
74.67 percent
0 references
3 January 2016
0 references
3 January 2018
0 references
HEARTGENETICS GENETICS AND BIOTECHNOLOGY, S.A.
0 references
Cantanhede
0 references
23 May 2023
0 references
Identifiers
CENTRO-01-0247-FEDER-010500
0 references